<p>This study presents and evaluates an automated volumetric modulated arc therapy (VMAT) planning framework for breast cancer based on objective function value (OFV)–guided optimization. The primary objective is to systematically improve organ-at-risk sparing through automated and reproducible optimization of planning constraints while maintaining clinically acceptable target coverage. An OFV-guided optimization workflow was empirically developed using a separate sensitivity dataset and subsequently evaluated in 20 clinical breast cancer patients (13 left-sided, 7 right-sided). The automated Python-based framework iteratively adapts MaxEUD constraints during optimization until dose metrics converge, without manual intervention. Automatically generated plans were compared to clinically delivered VMAT plans using target coverage, dose–volume metrics, and monitor units as a surrogate for delivery efficiency. The automated approach consistently achieved significant reductions in mean organ doses and low-dose volumes (e.g., <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(V_{2Gy}\)</EquationSource> </InlineEquation>, <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(V_{5Gy}\)</EquationSource> </InlineEquation>) while preserving PTV coverage. Mean heart dose decreased from <InlineEquation ID="IEq3"> <EquationSource Format="TEX">\(3.09 \pm 1.06\)</EquationSource> </InlineEquation> Gy to <InlineEquation ID="IEq4"> <EquationSource Format="TEX">\(2.21 \pm 0.69\)</EquationSource> </InlineEquation> Gy for left-sided cases and from <InlineEquation ID="IEq5"> <EquationSource Format="TEX">\(1.88 \pm 1.06\)</EquationSource> </InlineEquation> Gy to <InlineEquation ID="IEq6"> <EquationSource Format="TEX">\(1.17 \pm 0.25\)</EquationSource> </InlineEquation> Gy for right-sided cases (<InlineEquation ID="IEq7"> <EquationSource Format="TEX">\(p < 0.001\)</EquationSource> </InlineEquation>). Significant dose reductions were also observed for the ipsilateral lung, contralateral lung, and contralateral breast, accompanied by a 16.9 % reduction in monitor units (<InlineEquation ID="IEq8"> <EquationSource Format="TEX">\(p < 0.001\)</EquationSource> </InlineEquation>) and reduced inter-patient variability. In contrast, no statistically significant difference was observed for lung <InlineEquation ID="IEq9"> <EquationSource Format="TEX">\(V_{20Gy}\)</EquationSource> </InlineEquation>. In conclusion, OFV-guided VMAT optimization enables reproducible and systematic improvement of organ-at-risk sparing in breast radiotherapy. By reducing organ doses, low-dose burden, monitor units, and inter-patient variability without compromising target coverage, the proposed framework could provide a robust and standardized baseline for clinical VMAT planning and a consistent foundation for future data-driven and machine-learning–based optimization approaches.</p>

Objective-function-guided automated VMAT planning reduces OAR dose, low-dose exposure, and inter-planner variability in breast radiotherapy

期刊论文
出版模式：

开放获取
发表日期：

2026年5月21日

查看全文

Hannes Rennau,
Guido Hildebrandt

摘要

This study presents and evaluates an automated volumetric modulated arc therapy (VMAT) planning framework for breast cancer based on objective function value (OFV)–guided optimization. The primary objective is to systematically improve organ-at-risk sparing through automated and reproducible optimization of planning constraints while maintaining clinically acceptable target coverage. An OFV-guided optimization workflow was empirically developed using a separate sensitivity dataset and subsequently evaluated in 20 clinical breast cancer patients (13 left-sided, 7 right-sided). The automated Python-based framework iteratively adapts MaxEUD constraints during optimization until dose metrics converge, without manual intervention. Automatically generated plans were compared to clinically delivered VMAT plans using target coverage, dose–volume metrics, and monitor units as a surrogate for delivery efficiency. The automated approach consistently achieved significant reductions in mean organ doses and low-dose volumes (e.g., \(V_{2Gy}\) , \(V_{5Gy}\) ) while preserving PTV coverage. Mean heart dose decreased from \(3.09 \pm 1.06\) Gy to \(2.21 \pm 0.69\) Gy for left-sided cases and from \(1.88 \pm 1.06\) Gy to \(1.17 \pm 0.25\) Gy for right-sided cases ( \(p < 0.001\) ). Significant dose reductions were also observed for the ipsilateral lung, contralateral lung, and contralateral breast, accompanied by a 16.9 % reduction in monitor units ( \(p < 0.001\) ) and reduced inter-patient variability. In contrast, no statistically significant difference was observed for lung \(V_{20Gy}\) . In conclusion, OFV-guided VMAT optimization enables reproducible and systematic improvement of organ-at-risk sparing in breast radiotherapy. By reducing organ doses, low-dose burden, monitor units, and inter-patient variability without compromising target coverage, the proposed framework could provide a robust and standardized baseline for clinical VMAT planning and a consistent foundation for future data-driven and machine-learning–based optimization approaches.